| Literature DB >> 28962430 |
Benjamin Edokpolo1, Qiming Jimmy Yu1, Des Connell2.
Abstract
Health risk characterization of exposure to benzene in service stations and petroleum refineries has been carried out in previous studies using guideline values set by various agencies. In this work, health risk was characterized with the exposure data as cumulative probability distribution (CPD) plots but using human epidemiological data. This was achieved by using lowest observable adverse effects levels (LOAEL) data plotted as cumulative probability lowest effects distribution (CPLED). The health risk due to benzene was characterized by using probabilistic methods of hazard quotient (HQ50/50 and HQ95/5), Monte-Carlo simulation (MCS) and overall risk probability (ORP). CPD relationships of adverse health effects relationships and exposure data were in terms of average daily dose (ADD) and lifetime average daily dose (LADD) for benzene. For service station environments HQ50/50 and HQ95/5 were in a range of 0.000071-0.055 and 0.0049-21, respectively. On the other hand, the risk estimated for petroleum refinery environments suggests higher risk with HQ50/50 and HQ95/5 values ranging from 0.0012 to 77 and 0.17 to 560, respectively. The results of Monte-Carlo risk probability (MRP) and ORP indicated that workers in petroleum refineries (MRP of 2.9-56% and ORP of 4.6-52% of the affected population) were at a higher risk of adverse health effects from exposure to benzene as compared to exposure to benzene in service station environments (MRP of 0.051 -3.4% and ORP of 0.35-2.7% affected population). The adverse effect risk probabilities estimated by using the Monte-Carlo simulation technique and the ORP method were found to be generally consistent.Entities:
Keywords: Benzene exposure; Hazard quotient; Human epidemiological data; Monte-Carlo simulation; Overall risk probability
Year: 2015 PMID: 28962430 PMCID: PMC5598410 DOI: 10.1016/j.toxrep.2015.06.004
Source DB: PubMed Journal: Toxicol Rep ISSN: 2214-7500
Benzene inhalation data from service stations and petroleum refinery environments
| Scenario | Number of data points | Mean | Standard Deviation | Range (Min–Max) | Reference |
|---|---|---|---|---|---|
| Service station environments | |||||
| S1 (Attendants) | 74 | 510 | 570 | 1.9– 2900 | |
| S2 (Mechanics) | 10 | 230 | 160 | 50–540 | |
| S3 (Within) | 168 | 21 | 33 | 1.1–220 | |
| S4 (Office) | 9 | 4.7 | 5.9 | 1.6–21 | |
| S5 (Customers) | 7 | 1800 | 1600 | 150–4900 | |
| S6 (External) | 546 | 15 | 24 | 0.7–190 | |
| Petroleum refinery environments | |||||
| R1 (Base Estimates) | 95 | 3600 | 5800 | 3.3–28,000 | |
| R2A (Workers) | 66 | 110 | 170 | 0.22–830 | |
| R2B (Workers) | 8 | 17000 | 24000 | 3500–78,000 | |
| R3A (Inside) | 52 | 120 | 290 | 3.8–2000 | |
| R3B (Inside) | 28 | 14000 | 12000 | 4000–65,000 | |
| R4 (Outside) | 68 | 64 | 110 | 0.8–580 | |
aNumber of data points represents the affected population in the cumulative probability distribution (CPD) plots.
Reported toxicity data for human exposure to benzene.
| Short term exposure in terms of add | ||||||
|---|---|---|---|---|---|---|
| LOAEL (μg/m3) | ED | EL (day/day) | LOAEL–ADD (μg/kg/day) | Observed Health Effects | Reference | |
| 6.38 × 107 | 1 | 0.01 | 1.82 × 105 | Death | ||
| 1.91 × 105 | 1 | 0.1 | 5.47 × 103 | Drowsiness, dizziness, headaches, strong odour, fatigue | ||
| 9.57 × 105 | 0.5 | 0.04 | 1.09 × 104 | Drowsiness, headaches, dizziness | ||
| 191 × 105 | 1 | 0.1 | 5.47 × 103 | Mucous membrane irritation | ||
| 1.91 × 105 | 21 | 0.33 | 1.81 × 104 | Mucous membrane irritation, dyspnea | ||
| Long term exposure—non cancinogenic effects in terms of add | ||||||
| LOAEL (μg/m3) | ED | EL (day/day) | LOAEL–ADD (μg/kg/day) | Observed Health Effects | Reference | |
| 4.79 × 105 | 5475 | 0.33 | 4.51 × 104 | Hematotoxicity– Pancytopenia | ||
| 9.57 × 103 | 1095 | 0.33 | 9.02 × 102 | Hematotoxicity–Anemia, lymphocytosis, leukopenia, | ||
| 6.69 × 105 | 365 | 0.33 | 6.32 × 104 | Hematotoxicity– Pancytopenia, hypercellular bone marrow | ||
| 1.28 × 105 | 365 | 0.33 | 1.21 × 104 | Hematotoxicity–Decrease in white blood cells counts | ||
| 9.25 × 104 | 6935 | 0.33 | 8.72 × 103 | Hematotoxicity–Aplastic, anemia | ||
| 6.38 × 101 | 7665 | 0.33 | 6.02 | Hematotoxicity–Aplastic, anemia | ||
| 7.98 × 104 | 10585 | 0.33 | 7.52 × 103 | Hematotoxicity–Increased mean corpuscular volume | ||
| 1.82 × 103 | 2190 | 0.33 | 1.71 × 102 | Hematotoxicity–Reduced WBC and platelet counts | ||
| 7.21 × 103 | 3541 | 0.33 | 6.79 × 102 | Hematotoxicity–Reduced neutrophils and RBC counts | ||
| 2.42 × 104 | 2300 | 0.33 | 2.29 × 103 | Hematotoxicity–Reduced absolute lymphocyte count | ||
| 6.69 × 105 | 365 | 0.33 | 6.32 × 104 | Immunological– hypoplastic to hyperplastic bone marrow | ||
| 1.28 × 105 | 365 | 0.33 | 1.21 × 104 | Immunological– Decreased lymphocytes | ||
| 3.53 × 104 | 1852 | 0.33 | 3.33 × 103 | Immunological–Anemia, macrocytosis, thrombocytopeniav | ||
| 2.39 × 105 | 9125 | 0.33 | 2.26 × 104 | Immunological– Leukopenia | ||
| 6.67 × 105 | 365 | 0.33 | 6.29 × 104 | Immunological– Pancytopenia | ||
| 1.28 × 105 | 365 | 0.33 | 1.21 × 104 | Immunological–Decreased lymphocytes | ||
| 3.51 × 104 | 1852 | 0.33 | 3.31 × 103 | Immunological–Anemia, macrocytosis, thrombocytopeniav | ||
| 2.20 × 103 | 365 | 0.33 | 2.08 × 102 | Immunological– Leukopenia | ||
| 6.06 × 103 | 6205 | 0.33 | 5.71 × 102 | Reproductive–increased in chromosome aberration | ||
| 3.19 × 103 | 2190 | 0.33 | 3.01 × 102 | Reproductive–increased in chromosome aberration | ||
| 6.87 × 101 | 2210 | 0.33 | 6.48 | Reproductive–increased in chromosome aberration | ||
| Long term exposure – cancinogenic effects in terms of add & ladd | ||||||
| LOAEL (μg/m3) | ED | EL (day/day) | LOAEL–ADD (μg/kg/day) | LOAEL–LADD (μg/kg/day) | Observed health effect | Reference |
| 4.79 × 105 | 5475 | 0.33 | 4.51 × 104 | 9.67 × 103 | Cancer–Leukemia | |
| 3.19 × 105 | 2590 | 0.33 | 3.01 × 104 | 3.05 × 103 | Cancer–Leukemia | |
| 9.25 × 104 | 6935 | 0.33 | 8.72 × 103 | 2.37 × 103 | Cancer– Human lymphocytic leukemia | |
| 3.19 × 103 | 14,600 | 0.33 | 3.01 × 102 | 1.72 × 102 | Cancer–Leukemia | |
| 9.57 × 102 | 548 | 0.33 | 9.02 | 1.94 | Cancer– Leukemia | |
| 5.1 × 104 | 5110 | 0.33 | 4.81 × 103 | 9.62 × 102 | Cancer– Leukemia | |
| 2.74 × 103 | 2555 | 0.33 | 2.59 × 102 | 2.58 × 101 | Cancer– Acute myeloid leukemia | |
| 5.1 × 104 | 5110 | 0.33 | 4.81 × 103 | 9.62 × 102 | Cancer– Leukemia | |
| 6.87 × 103 | 365 | 0.33 | 6.48 × 102 | 9.25 | Cancer– Chronic erythroid leukemia | |
| 6.38 × 105 | 10950 | 0.33 | 6.02 × 104 | 2.58 × 104 | Cancer– Leukemia | |
| 3.19 × 104 | 3650 | 0.33 | 3.01 × 103 | 4.29 × 102 | Cancer– Leukemia | |
LOAEL – Lowest observed adverse effects levels.
ED – Exposure duration (day).
EL – Exposure length (day/day).
LT – Lifetime (70 years × 365 days = 25,550 day).
IR – Inhalation rate (20 m3/day).
BW – Body weight (70 kg).
0.33 day/day (8 h/d) is assumed to be equivalent occupational exposure.
Fig. 1Math Image deleted from here. CPD for exposure scenarios for benzene in service station environments (S1–S6 see Section 2.1) with corresponding CPLED adverse health effects for short term exposure [LOAEL – ADD (A and B)]; long term exposure [LOAEL – ADD (C and D)]; lifetime average exposure [LOAEL – LADD (E and F)].
Fig. 2CPD for exposure scenarios forbenzene in petroleum refinery environments (R1, R2A,B, R3A, B, R4 see Section 2.1) with corresponding CPLED adverse health effects for short term exposure [LOAEL – ADD (A and B)]; long term exposure [LOAEL – ADD (C and D)]; lifetime average exposure [LOAEL – LADD (E and F)].
Health risk outcomes derived for ORP, MRP and HQ95/5.
| Scenario | STE (ADD) {1–28 days (<1 h/day)}, | LTE (ADD) {>6months 8 h/day} | LAE (LADD) (70 years) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ORP (%) | MRP (%) | HQ50/50 | HQ95/5 | ORP (%) | MRP (%) | HQ50/50 | HQ95/5 | ORP (%) | MRP (%) | HQ50/50 | HQ95/5 | |
| Service station environments | ||||||||||||
| S1 (attendants) | 1.7 | 0.78 | 0.0012 | 0.55 | 17 | 15 | 0.0038 | 8.8 | 2.7 | 3.4 | 0.055 | 21 |
| S2 (mechanics) | 0.57 | 0.34 | 0.00093 | 0.27 | 12 | 7.9 | 0.0029 | 4.4 | 2.1 | 2.4 | 0.041 | 7.5 |
| S3 (within) | 0.35 | 0.15 | 0.000024 | 0.23 | 6.7 | 3.2 | 0.000074 | 3.8 | 1.3 | 0.96 | 0.0011 | 0.72 |
| S4 (office) | 0.28 | 0.043 | 0.000071 | 0.0049 | 2.2 | 0.93 | 0.00022 | 0.078 | 0.57 | 0.30 | 0.0031 | 0.23 |
| S5 (customers) | 0.35 | 0.086 | 0.000029 | 0.037 | 4.4 | 1.8 | 0.000094 | 0.59 | 0.57 | 0.15 | 0.0013 | 0.31 |
| S6 (external) | 0.35 | 0.051 | 0.000036 | 0.0061 | 2.8 | 1.3 | 0.00011 | 0.096 | 0.57 | 0.18 | 0.0016 | 0.68 |
| Petroleum refinery environments | ||||||||||||
| R1 (base estimates) | 15 | 13 | 0.10 | 9.2 | 22 | 30 | 0.31 | 150 | 38 | 37 | 4.5 | 120 |
| R2A (workers) | 6.5 | 3.4 | 0.0077 | 0.92 | 9.5 | 7.5 | 0.024 | 14 | 17 | 29 | 0.34 | 5.0 |
| R2B (workers) | 29 | 23 | 1.8 | 24 | 47 | 49 | 5.5 | 375 | 52 | 56 | 77 | 560 |
| R3A (inside) | 6.5 | 3.3 | 0.0023 | 0.31 | 9.5 | 6.9 | 0.0071 | 5.0 | 17 | 28 | 0.10 | 4.7 |
| R3B (inside) | 27 | 20 | 1.1 | 19 | 44 | 47 | 3.5 | 310 | 47 | 52 | 51 | 380 |
| R4 (outside) | 4.6 | 2.9 | 0.0012 | 0.17 | 6.4 | 3.8 | 0.0039 | 2.7 | 11 | 18 | 0.055 | 2.3 |
LOAEL–ADD – Lowest observed adverse effects average daily dose.
LOAEL–LADD – Lowest observed adverse effects lifetime average daily dose.
Fig. 3Examples of simulated probability distribution density for A, service station attendants (Scenario S1) exposure to benzene evaluated for STE and B, petroleum refinery workers exposure to benzene (Scenario R2A) evaluated for STE using human data.
Fig. 4Overall risk probability curve derived for A, short term; B, long term and C, lifetime exposure to benzene in service station environments (see Fig. 1).
Fig. 5Overall risk probability curve derived for A, short term; B, long term and C, lifetime exposure to benzene in petroleum refinery environments (see Fig. 1).
Fig. 6Relationship between overall risk probability of affected population (%) and Monte-Carlo risk probability (MRP) of HQ greater than unity (%) for exposure to benzene in service stations and petroleum refinery environments.
Fig. 7Relationship between overall risk percentage probability (ORP) of affected population (%) and hazard quotient A, 50%CP (HQ50/50) and B, 95%CP (HQ95/5) for exposure to benzene in service stations and petroleum refinery environments.